Evidence map›Paper›PMID 36359238›Full record

ArticleBiomedicines2022

Phenotype and Neuronal Cytotoxic Function of Glioblastoma Extracellular Vesicles.

Wenbo Zhou, Daniel Lovasz, Zoë Zizzo, Qianbin He, Christina Coughlan, Robert G Kowalski, Peter G E Kennedy, Arin N Graner, Kevin O Lillehei, D Ryan Ormond and 3 more

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Specific Binding of Alzheimer's Aβ Peptides to Extracellular Vesicles.International journal of molecular sciences · 2024
    Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

Wenbo ZhouDepartment of Neurosurgery, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
Daniel LovaszDepartment of Neurosurgery, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
Zoë ZizzoDepartment of Neurosurgery, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.ORCID 0000-0003-4492-075X
Qianbin HeDepartment of Neurosurgery, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
Christina CoughlanDepartment of Neurology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
Robert G KowalskiDepartment of Neurosurgery, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
Peter G E KennedyInstitute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow G12 8QQ, UK.ORCID 0000-0002-8420-8583
Arin N GranerDepartment of Neurosurgery, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
Kevin O LilleheiDepartment of Neurosurgery, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
D Ryan OrmondDepartment of Neurosurgery, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
A Samy YoussefDepartment of Neurosurgery, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
Michael W GranerDepartment of Neurosurgery, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.ORCID 0000-0002-3097-0257
Xiaoli YuDepartment of Neurosurgery, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.ORCID 0000-0003-4850-8586
University of Colorado Anschutz Medical Campus · USUniversity of Glasgow · GB

Funding

Development of Validation of Phage-Displayed Random Peptide Libraries Technologies for Rapid Isolation and Characterization of Extracellular Vesicles from Patients with Brain TumorsR33MH118174 · NIMH · UNIVERSITY OF COLORADO DENVER · PI GRANER, MICHAEL W., YU, XIAOLI · 2020 to 2022
$1.9M
Development of Validation of Phage-Displayed Random Peptide Libraries Technologies for Rapid Isolation and Characterization of Extracellular Vesicles from Patients with Brain TumorsR21MH118174 · NIMH · UNIVERSITY OF COLORADO DENVER · PI GRANER, MICHAEL W., YU, XIAOLI · 2018 to 2019
$423k
NIMH NIH HHS 4R33MH118174NIMH NIH HHS NIMH1R21MH118174-01NIMH NIH HHS R21 MH118174NIMH NIH HHS R33 MH118174
6 · The paper itself

Abstract

Glioblastoma (GBM) is the most aggressive and lethal form of brain tumor. Extracellular vesicles (EVs) released by tumor cells play a critical role in cellular communication in the tumor microenvironment promoting tumor progression and invasion. We hypothesized that GBM EVs possess unique characteristics which exert effects on endogenous CNS cells including neurons, producing dose-dependent neuronal cytotoxicity. We purified EVs from the plasma of 20 GBM patients, 20 meningioma patients, and 21 healthy controls, and characterized EV phenotypes by electron microscopy, nanoparticle tracking analysis, protein concentration, and proteomics. We evaluated GBM EV functions by determining their cytotoxicity in primary neurons and the neuroblastoma cell line SH-SY5Y. In addition, we determined levels of IgG antibodies in the plasma in GBM (n = 82), MMA (n = 83), and controls (non-tumor CNS disorders and healthy donors, n = 50) with capture ELISA. We discovered that GBM plasma EVs are smaller in size and had no relationship between size and concentration. Importantly, GBM EVs purified from both plasma and tumor cell lines produced IgG-mediated, complement-dependent apoptosis and necrosis in primary human neurons, mouse brain slices, and neuroblastoma cells. The unique phenotype of GBM EVs may contribute to its neuronal cytotoxicity, providing insight into its role in tumor pathogenesis.

Indexed as

apoptosisC1qcomplementcytotoxicityextracellular vesiclesFcglioblastomaIgGmeningiomaneuroblastomaneuronsplasma

Identifiers

PMID36359238
PMCPMC9688005
OpenAlexW4307630695

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.